Singapore Clinical Research Institute

What Singapore Clinical Research Institute does

Singapore Clinical Research Institute (SCRI) is a Singapore Government agency operating as the national academic research organisation (ARO) dedicated to enhancing the standards of clinical research. It coordinates clinical trial activities across Singapore's three public healthcare clusters — SingHealth, National Health Group (NHG) and National University Health System (NUHS) — and serves as the central convening body for investigator-initiated and sponsored trials in the country, operating under the Ministry of Health and within the Consortium for Clinical Research and Innovation Singapore (CRIS) corporate structure. SCRI's mandate aligns with Singapore's Research, Innovation and Enterprise 2025 (RIE2025) plan, with early-phase clinical trials identified as a national focus area.

SCRI's core offerings fall into three pillars. First, as a National Coordinating Body, it operates SCRI Academy (Singapore's first national learning and development platform for Clinical Research Coordinators, offering Level 1-3 certification programmes, internship, onboarding and e-learning courses), the centralised Singapore Clinical Trials Portal (CTSG), and the pre-negotiated Master Clinical Trial Agreement (MCTA) template developed with the Singapore Association for Pharmaceutical Industries (SAPI) and the three public healthcare clusters to shorten multi-site contract review. Second, as an Academic Research Organisation, it provides clinical trial support, data and technology services, health economics and outcomes research (HEOR), and clinical R&D services including the ATOM3 featured project. Third, it coordinates a portfolio of 13+ disease-specific clinical research networks spanning oncology (SMSG, ICaN Asia, AHCC, AMN, GCGS, ATORG), emergency and pre-hospital care (PAROS CRN), pediatrics (PACCMAN, PIBD), cardiovascular (ASPIRE), renal genetics (DRAGoN) and adrenal hypertension (ANAH), with regional ties to partners including the International Myeloma Foundation, Asian Myeloma Network, CARES and NAEMSP.

SCRI employs 51-100 staff and is funded primarily through Singapore Government appropriations; it does not publicly disclose pricing for its coordination, training and support services. Its go-to-market is institutional rather than commercial, engaging public healthcare clusters, regulators (HSA), industry associations (SAPI), clinician investigators, CRCs, patients and caregivers through training programmes, an annual SCRI Clinical Trials Symposium (next edition scheduled for 30-31 July 2026), and the CTSG portal. No revenue figures, funding rounds, M&A activity, patents or proprietary AI capabilities are disclosed in the source material.

Name

Singapore Clinical Research Institute

Legal name

Consortium for Clinical Research and Innovation Singapore

Website

https://scri.edu.sg

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

51–100 employees

Short description

Singapore Clinical Research Institute (SCRI) is a Singapore Government agency and the national academic research organisation coordinating clinical trials, CRC training, and 13+ disease-specific research networks across SingHealth, NHG, NUHS and the Asia-Pacific region.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Clinical Trial Site Operations & Study Coordination (HLAGACAE), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Medical Writing & Regulatory Submission Support CROs (HLAGAAAG), Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA)

Keywords

• Clinical research services
• Academic research organization
• Clinical trial coordination
• Clinical research training
• Health economics research

Headquarters

HQ city

Singapore

HQ country

Singapore

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Government Funding: SCRI is a Singapore Government agency operating as the national academic research organisation. The organization receives government funding to support its mandate of enhancing clinical research standards in Singapore.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

SCRI operates as Singapore's national academic research organization, providing clinical trial coordination and support, Clinical Research Coordinator (CRC) training and certification through SCRI Academy, Health Economics and Outcomes Research (HEOR), data management, and clinical R&D services. It coordinates 13+ disease-specific clinical research networks across the Asia-Pacific region and operates the centralized Singapore Clinical Trials Portal (CTSG) and the Master Clinical Trial Agreement (MCTA) template to streamline multi-site trial contracting.

Product overview

Singapore Clinical Research Institute (SCRI) operates as a national academic research organization providing an integrated ecosystem of clinical research services. The core offerings include SCRI Academy, a national learning and development platform for Clinical Research Coordinators offering Level 1-3 certification programs, internship and onboarding programs, and e-learning courses; Singapore's Clinical Trials Portal (CTSG), a centralized portal for clinical trial information; and the Master Clinical Trial Agreement (MCTA) template for streamlining multi-site trial agreements. SCRI also coordinates a network of disease-specific Clinical Research Networks spanning oncology (Singapore Myeloma Study Group, ICaN Asia, AHCC, AMN, GCGS), emergency care (PAROS CRN), pediatrics (PACCMAN, PIBD), cardiovascular (ASPIRE), genetics (DRAGoN), and thoracic oncology (ATORG). The organization supports the full clinical trial lifecycle from training and site coordination to network-based collaborative research across the Asia-Pacific region.

Differentiator

Problem solved

Functional benefit

Products and services

• SCRI Academy National learning and development platform for Clinical Research Coordinators (CRCs) in Singapore, offering structured training, certification (Level 1, 2, 3), internship, onboarding, and e-learning programs for clinical research professionals.
• CRC Level 1 Programme A 7-day training course covering protocol feasibility, study start-up, ethics and regulation, recruitment, and study closure for Clinical Research Coordinators with at least one year of experience.
• CRC Level 2 Programme A 6-day training course developing project management and investigator-initiated clinical research coordination skills for Senior CRCs with at least four years of experience.
• CRC Level 3 Programme An advanced 4-day training course developing departmental planning and team management capabilities for Senior CRCs with at least eight years of experience.
• CRC Internship Programme A comprehensive 6-month internship program at public healthcare institutions providing hands-on CRC role experience and clinical trial conduct insights.
• CRC Onboarding Programme A coaching programme of two half-day sessions for newly-hired CRCs with less than one year of experience, providing essential theoretical knowledge and practical tips for navigating basic duties.
• The Essentials of Clinical Trials for Beginners (E-learning) A 16-week self-paced online e-learning course providing fundamental knowledge on clinical trials for those new to the field, covering all basic knowledge required of a CRC to conduct a trial at site.
• The Essentials of Clinical Trials for Investigators (E-Learning) A 16-week self-paced online e-learning course equipping clinician investigators with essential skills for navigating clinical trial activities, covering operational knowledge including administrative tasks, regulatory landscape, screening and recruitment.
• Singapore's Clinical Trials Portal (CTSG) Centralised web-based portal for all matters pertaining to clinical trials in Singapore, providing comprehensive support and information for patients, caregivers, clinical investigators and corporations.
• Master Clinical Trial Agreement (MCTA) Pre-negotiated Master Clinical Trial Agreement template developed with Singapore Association for Pharmaceutical Industries (SAPI) and the three public sector healthcare clusters to shorten contract review time for sponsored multi-site clinical trials in Singapore.
• PAROS CRN (Pan-Asian Resuscitation Outcomes Study Clinical Research Network) Collaborative research network formed in 2010 by Pre-hospital and Emergency Care providers conducting research across Asia-Pacific to improve outcomes from cardiac arrest, trauma, heart attack and stroke.
• PACCMAN (Pediatric Acute & Critical Care Medicine Asian Network) Collaborative research network formed in 2015 by pediatric intensive care providers supporting research into effective strategies to improve survival in critically ill children, focusing on sepsis, ARDS and myocarditis.
• Singapore Myeloma Study Group (SMSG) Research network carrying out clinical trials to bring new treatments to Singapore Myeloma patients, developing practice guidelines and collaborating with the Asian Myeloma Network (AMN) and International Myeloma Foundation (IMF).
• Inherited Cancers Network Asia (ICaN Asia) Network established in 2025 focused on improving health outcomes for individuals with hereditary cancers across the Asia-Pacific region through empowerment, education, engagement, enabling research and elevating standards of care.
• Asia Pacific Hepatocellular Carcinoma (AHCC) Trials Group Regional network focusing on hepatocellular carcinoma clinical trials and research collaboration across the Asia Pacific region.
• Asia Pacific Cardiovascular Research Network (ASPIRE) Network focusing on cardiovascular research collaboration across the Asia Pacific region.
• Asian Myeloma Network (AMN) Regional network focused on myeloma research and clinical trials, operating under the International Myeloma Foundation.
• Asian Thoracic Oncology Research Group (ATORG) Regional network focused on thoracic oncology research and clinical trials.
• ASEAN Network of Adrenal Hypertension (ANAH) Network focused on adrenal hypertension research across ASEAN countries.

Quantifiable outcome

• Reduced contract negotiation time from up to 6 months using pre-negotiated MCTA template
• +1 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Twelve partnerships are on record, tiered core, major and minor.

• Singapore Association for Pharmaceutical Industries (SAPI)coreStrategic or Co-development PartnerSAPI collaborated with SCRI and the three public healthcare clusters to develop the Master Clinical Trial Agreement (MCTA) template, pre-negotiating terms and conditions to shorten contract review time for sponsored clinical trials in Singapore.
• Singapore Health Services (SingHealth)coreStrategic or Co-development PartnerOne of three public sector healthcare clusters participating in the MCTA agreement and coordinating clinical trial efforts nationally through SCRI.
• National Health Group (NHG)coreStrategic or Co-development PartnerOne of three public sector healthcare clusters participating in the MCTA agreement and coordinating clinical trial efforts nationally through SCRI.
• National University Health System (NUHS)coreStrategic or Co-development PartnerOne of three public sector healthcare clusters participating in the MCTA agreement and coordinating clinical trial efforts nationally through SCRI.
• Health Sciences Authority (HSA)coreStrategic or Co-development PartnerSCRI consulted HSA as a Subject Matter Expert when developing national CRC training programmes aligned with Singapore regulatory frameworks (e.g., ICH-GCP).
• International Myeloma Foundation (IMF)majorStrategic or Co-development PartnerSMSG members are part of the Asian Myeloma Network (AMN) formed under IMF auspices, participating in AMN activities including clinical trials, physician education, and patient support outreach.
• Asian Myeloma Network (AMN)majorStrategic or Co-development PartnerInternational network under IMF through which SMSG members participate in leading clinical trials and driving network activities including physician education and patient support.
• Singapore Translational Cancer Consortium (STCC)coreStrategic or Co-development PartnerSMSG is managed by STCC, providing translational cancer research infrastructure and leadership including Prof Chng Wee Joo as Executive Director.
• Asian Emergency Medical Services (EMS) CouncilmajorStrategic or Co-development PartnerPAROS CRN is affiliated with the Asian EMS Council, promoting pre-hospital care research collaboration across Asia.
• Cardiac Arrest Registry to Enhance Survival (CARES)majorStrategic or Co-development PartnerPAROS CRN has forged ties with CARES in the USA, showcasing collaboration with parties beyond the Asia-Pacific region for cardiac arrest research.
• National Association of EMS Physicians (NAEMSP)minorStrategic or Co-development PartnerPAROS CRN is affiliated to the Asian Relations Ad Hoc Committee of NAEMSP for pre-hospital care research standards.
• Overseas Education PartnersmajorStrategic or Co-development PartnerSCRI Academy collaborates with overseas training providers to develop and implement structured national CRC training programmes alongside local partners.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• ICON plc: Global clinical research organization providing Phase I–IV trial execution, laboratory, and consulting services. Comparable as a competing full-service CRO bidding for the same sponsored trials SCRI coordinates in the region.
• IQVIA: The world's largest CRO offering full-service Phase I–IV clinical trial management, data, and biostatistics. Competes with SCRI for sponsored trial work in Singapore and Asia-Pacific but at a vastly broader scale and therapeutic breadth.
• Syneos Health: Biopharmaceutical services organization combining CRO capabilities with commercial solutions. Competes with SCRI for Asia-Pacific clinical trial sponsorships, particularly in late-phase and post-approval studies.
• PAREXEL International: Large global CRO offering clinical trial management, biostatistics, regulatory, and pharmacovigilance services. Overlaps with SCRI's data management, regulatory, and clinical operations functions for international sponsors.

Direct peers

• Clinical Research Malaysia (CRM): Malaysia's national clinical research organization sponsored by the Ministry of Health, providing site coordination, training, and sponsored trial development. Highly comparable to SCRI as a Southeast Asian national CRO/ARO with government backing.
• CTI Clinical Trial & Consulting Services: Mid-sized academic-style CRO offering Phase I–IV trial management, biostatistics, and pharmacovigilance. Comparable in scale and academic-affiliated operating model to SCRI's clinical R&D and data/technology functions.
• Duke Clinical Research Institute (DCRI): A leading academic research organization embedded within Duke University that conducts multi-site clinical trials, data management, biostatistics, and health economics research. Directly comparable to SCRI's academic research organization model and end-to-end clinical research support scope.
• European Clinical Research Infrastructure Network (ECRIN): Pan-European non-profit infrastructure coordinating national clinical research networks across multiple countries. Directly comparable as a multi-country ARO model focused on coordinating investigator-initiated and sponsored trials through standardized agreements and training.

Others

• Consortium for Clinical Research and Innovation Singapore (CRIS): The Singapore consortium under which SCRI operates, encompassing national-level clinical research and innovation entities. Highly adjacent as the parent/corporate entity maintaining SCRI's website and shared infrastructure.

Regional players

• Singapore Health Services (SingHealth): One of Singapore's three public healthcare clusters and a core SCRI partner for clinical trial conduct. Comparable as a regional site-network operator that SCRI coordinates, with overlapping investigator and patient populations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/697513

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Singapore Clinical Research Institute